Title: “Multimodal imaging in the preclinical phase of Alzheimer’s disease.”
Alzheimer’s disease (AD) is the most common cause of dementia, affecting almost half of Canadians aged 85 years or older. Amyloid-beta (Aβ) plaques and neurofibrillary tau tangles are the pathological hallmarks of AD that appear years before cognitive impairments can be detected. Unless the disease can be prevented, the prevalence of dementia is expected to increase dramatically with the aging of the population. Dr. Sylvia Villeneuve will discuss the brain changes that characterize the preclinical phase of the disease. Dr. Villeneuve will also discuss the potential modifiable risk factors that could slow down disease progression, and explain how altering new imaging and fluid (plasma and cerebrospinal fluid) criteria can help to identify individuals in the preclinical phase of AD.
Attend in person at 2269 Beckman Institute or join via Zoom.
